JULLIEN MOWATT: Open Payments
NPI 1295474070 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 80 payments from 16 companies in 2025. Trend: 2023 $1,201 · 2024 $2,051 · 2025 $2,253
Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $634 |
| ABBVIE INC. | 10 | $269 |
| Axsome Therapeutics, Inc. | 9 | $217 |
| PFIZER INC. | 12 | $210 |
| Lilly USA, LLC | 11 | $166 |
| Novo Nordisk Inc | 9 | $158 |
| Phathom Pharmaceuticals, Inc. | 4 | $148 |
| INTUITIVE SURGICAL, INC. | 1 | $129 |
| LEO Pharma Inc. | 1 | $125 |
| Lundbeck LLC | 3 | $51 |
Products named: AIRSUPRA, Auvelity, MOUNJARO, BREZTRI, FARXIGA, VOQUEZNA, QULIPTA, Da Vinci Surgical System.
Industry payments across NY — which companies pay providers there.
